Patents Examined by Brian T. Gedeon
  • Patent number: 12172006
    Abstract: An electrical stimulation system includes a sheath that includes conductive points that are operative to facilitate electrical stimulation to a bodily portion of a user. Drive-sense circuits (DSCs) generate electrical stimulation signals based on reference signals and provide those electrical stimulation signals via electrodes to the conductive points of the sheath. The electrical stimulation signal is coupled into respective locations of the bodily portion of the user that are in proximity to or in contact with the conductive points of the sheath. In addition, the DSCs sense, via the conductive points of the sheath and via the electrodes, changes of the electrical stimulation signals based on coupling of them into the respective locations of the bodily portion of the user. The DSCs provide digital signals that are representative of the changes of the electrical stimulation signals to one or more processing modules that includes and/or is coupled to memory.
    Type: Grant
    Filed: July 26, 2022
    Date of Patent: December 24, 2024
    Assignee: SIGMASENSE, LLC.
    Inventors: John Christopher Price, Shayne X. Short, Timothy W. Markison
  • Patent number: 12172001
    Abstract: Methods of providing electrical neural modulation to a patient's brain are disclosed herein. The methods involve differentially modulating two or more target regions of the brain. For example, a first target region may be provided with an electrical neural modulation signal that activates that target region while a second target region is provided with an electrical neural modulation signal that suppresses or deactivates that target region. As the implantable pulse generators (IPGs) described herein include independent current sources, such differential modulation can be provided with a single IPG.
    Type: Grant
    Filed: May 10, 2022
    Date of Patent: December 24, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Hemant Bokil
  • Patent number: 12172004
    Abstract: Methods and systems for positioning a leadless pacing device (LPD) in cardiac tissue are disclosed. A delivery device is employed that comprises a proximal end, a distal end and a lumen therebetween sized to receive the LPD. The LPD has a leadlet extending therefrom that includes a means to fixate the leadlet to tissue. The delivery device comprises an introducer to introduce the LPD into the lumen of the delivery device. The LPD is loaded in the distal end of the lumen of the delivery device. The leadlet extends proximally from the LPD while the fixation means extends distally toward the LPD. A LPD mover is configured to advance the LPD out of the delivery device. A leadlet mover is configured to advance the leadlet out of the lumen delivery device and cause the leadlet to engage with cardiac tissue.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: December 24, 2024
    Assignee: Medtronic, Inc.
    Inventors: Ronald A. Drake, Kenneth C. Gardeski, Carla Pfeiffer, Kevin R. Seifert, Lester O. Stener, Matthew D. Bonner
  • Patent number: 12168165
    Abstract: Methods and program products for building a workout are disclosed. In an embodiment, a method for generating a workout includes the steps of receiving user input indicating features of a desired workout, generating a workout, wherein the workout comprises a plurality of intervals, and wherein a first interval comprises an interval intensity and an interval duration, and initiating a graphical display that conveys the number of intervals making up the workout and the interval intensity and the interval duration of the first interval.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: December 17, 2024
    Assignee: adidas AG
    Inventors: Christian Dibenedetto, Maya Ann Page, Stephen John Black
  • Patent number: 12157004
    Abstract: An electrical stimulation system includes a sheath that includes conductive points that are operative to facilitate electrical stimulation to a bodily portion of a user. Drive-sense circuits (DSCs) generate electrical stimulation signals based on reference signals and provide those electrical stimulation signals via electrodes to the conductive points of the sheath. The electrical stimulation signal is coupled into respective locations of the bodily portion of the user that are in proximity to or in contact with the conductive points of the sheath. In addition, the DSCs sense, via the conductive points of the sheath and via the electrodes, changes of the electrical stimulation signals based on coupling of them into the respective locations of the bodily portion of the user. The DSCs provide digital signals that are representative of the changes of the electrical stimulation signals to one or more processing modules that includes and/or is coupled to memory.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: December 3, 2024
    Assignee: SIGMASENSE, LLC.
    Inventors: John Christopher Price, Shayne X. Short, Timothy W. Markison
  • Patent number: 12133632
    Abstract: A method of assessing Fallopian tubal patency includes introducing a distension medium into a patient's uterus, introducing a contrasting medium into the uterus, and observing the contrasting medium, for example, via a hysteroscope, to determine whether the contrasting medium flows into one or both Fallopian tubes. A device for assessing Fallopian tubal patency includes a chamber for receiving contrast media, a flow path through the chamber for delivering distension media to a patient's uterus, and a flow controller for regulating the flow of distension media to the patient's uterus. The flow path is configured to permit flow of contrast media from the chamber into the flow path.
    Type: Grant
    Filed: January 13, 2023
    Date of Patent: November 5, 2024
    Assignee: Kokopelli Concepts, LLC
    Inventor: John Parry
  • Patent number: 12128244
    Abstract: Embodiments of a wearable cardioverter defibrillator (WCD) system are configured to monitor a patient's ECG for shockable arrhythmias and deliver a shock to the patient in response to such a detection. To monitor the patient's ECG with reduced signal noise to improve the system's performance, the system includes a cable assembly having: a signal line; an inner shield and an outer shield; an ECG electrode electrically connected to the signal line of the cable assembly; and an amplifier having first and second input nodes respectively connected to the signal line and the outer shield of the cable assembly. The amplifier's output node is electrically connected to the inner shield of the cable assembly to reduce the reactive load seen by the patient's heart in driving the ECG sensing circuitry, which reduces the noise on the ECG signal outputted by the amplifier.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: October 29, 2024
    Assignee: WEST AFFUM HOLDINGS DAC
    Inventors: Zhong Qun Lu, Douglas K. Medema, Kenneth F. Cowan
  • Patent number: 12128240
    Abstract: A system and method have at least one implantable lead comprising a right ventricular (RV) electrode and one or more left ventricular (LV) electrodes, at least one processor, and a memory coupled to the at least one processor. The memory stores program instructions.
    Type: Grant
    Filed: January 28, 2022
    Date of Patent: October 29, 2024
    Assignee: Pacesetter, Inc.
    Inventors: Jan O. Mangual-Soto, Nima Badie, Luke C. McSpadden
  • Patent number: 12102145
    Abstract: A material and apparel that positively affect the health and well-being of a mammal include fibers that are formed with a semiconductor. Upon contact of the material or apparel with a region of the mammal's body, a positive effect occurs that relates to the health and wellbeing of that mammal. The material includes a region that includes an expanse. The expanse is formed with a semiconductor and constructed for contact with the skin of the mammal. The apparel has a body that includes a region that has a wearable form made of a semiconductor, and is constructed for making contact with a human body when the human wears the apparel.
    Type: Grant
    Filed: August 17, 2023
    Date of Patent: October 1, 2024
    Assignee: Incrediwear Holdings, Inc.
    Inventor: Jackson Corley
  • Patent number: 12102825
    Abstract: A material and apparel that positively affect the health and well-being of a mammal include fibers that are formed with a semiconductor. Upon contact of the material or apparel with a region of the mammal's body, a positive effect occurs that relates to the health and wellbeing of that mammal. The material includes a region that includes an expanse. The expanse is formed with a semiconductor and constructed for contact with the skin of the mammal. The apparel has a body that includes a region that has a wearable form made of a semiconductor, and is constructed for making contact with a human body when the human wears the apparel.
    Type: Grant
    Filed: August 17, 2023
    Date of Patent: October 1, 2024
    Assignee: Incrediwear Holdings, Inc.
    Inventor: Jackson Corley
  • Patent number: 12102840
    Abstract: Dermatological systems and methods for providing picosecond laser pulses at a plurality of treatment wavelengths, wherein at least one of the wavelengths is provided by an optical parametric oscillator (OPO) capable of providing laser pulses at a wavelength for treating one or more target tissue types. In some embodiments, multiple OPOs may be provided to enable a wide range of selectable treatment wavelengths.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: October 1, 2024
    Assignee: Cutera, Inc.
    Inventors: Lukas E. Hunziker, Michael A. Karavitis, Hsiao-Hua Liu
  • Patent number: 12102450
    Abstract: Systems and methods are provided for evaluating physiological signal quality. A physiological signal, based on a series measurements on a subject, may be received. A quality of the physiological signal received may be evaluated, and an analysis of the physiological signal may be based at least in part on the quality evaluation.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: October 1, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Lukas Smital, David R. Holmes, III, Clifton R. Haider, Barry K. Gilbert
  • Patent number: 12097035
    Abstract: Disclosed systems and method receive electrocardiogram (EKG) data of a subject. The EKG data comprises a record of at least a full beat of the subject. The EKG data is input into a machine learning model to generate an output. The output can include a segmentation of the full beat or a measurement of a QT interval of the subject.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: September 24, 2024
    Assignee: ALIVECOR, INC.
    Inventors: David E. Albert, Alexander Vainius Valys, Conner Daniel Cross Galloway
  • Patent number: 12096809
    Abstract: A material and apparel that positively affect the health and well-being of a mammal include fibers that are formed with a semiconductor. Upon contact of the material or apparel with a region of the mammal's body, a positive effect occurs that relates to the health and wellbeing of that mammal. The material includes a region that includes an expanse. The expanse is formed with a semiconductor and constructed for contact with the skin of the mammal. The apparel has a body that includes a region that has a wearable form made of a semiconductor, and is constructed for making contact with a human body when the human wears the apparel.
    Type: Grant
    Filed: August 17, 2023
    Date of Patent: September 24, 2024
    Assignee: Incrediwear Holdings, Inc.
    Inventor: Jackson Corley
  • Patent number: 12083345
    Abstract: Techniques are disclosed for a multi-tier system for delivering therapy to a patient. In one example, a first device senses parametric data for a patient and determines, based on a first analysis of the parametric data, that the patient is experiencing a treatable event. In response, the first device establishes wireless communication with a second device and transmits the parametric data to the second device. The second device verifies, based on a second analysis of the parametric data, whether the patient is experiencing the treatable event. The second device selects, based on the second analysis of the parametric data, an instruction for responding to the treatable event and transmits the instruction for responding to the treatable event to the first device. In some examples, in response to receiving the instruction, the first device aborts delivery of therapy for the treatable event or proceeds with delivering therapy for the treatable event.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: September 10, 2024
    Assignee: Medtronic, Inc.
    Inventors: Tarek D. Haddad, Donald R. Musgrove, Andrew Radtke, Eric D. Corndorf, Paul J. DeGroot
  • Patent number: 12083352
    Abstract: The present disclosure relates generally to a defibrillator assembly comprising a defibrillator having a first operating mode for delivering a high energy output to a patient and a second operating mode for monitoring the patient, a first battery unit operably coupled to the defibrillator, and a second battery unit operably coupled to the defibrillator. One of the first battery unit and the second battery unit provides power to the defibrillator during the second operating mode. Both the first battery unit and the second battery unit provide power to the defibrillator during the first operating mode.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: September 10, 2024
    Assignee: Physio-Control, Inc.
    Inventors: Ryan W. Apperson, Mark Rutzer, Rockland W. Nordness, Kristina Edmonson, Chad Bartlett
  • Patent number: 12076569
    Abstract: A medical device includes a motion sensor for producing a motion signal including cardiac event signals. The medical device generates a ventricular pacing pulse upon expiration of a pacing interval. The medical device determines a synchrony metric from the motion signal after a delivered ventricular pacing pulse and adjusts the pacing interval based on the synchrony metric.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: September 3, 2024
    Assignee: Medtronic, Inc.
    Inventors: Wade M. Demmer, Alexander R. Mattson, Todd J. Sheldon, Zhongping Yang
  • Patent number: 12076170
    Abstract: A method for determining and responding in real-time to an increased risk of death relating to a patient with epilepsy is provided. The method includes receiving cardiac data and determining a cardiac index based upon the cardiac data. The method includes determining an increased risk of death associated with epilepsy if the indices are extreme, issuing a warning of the increased risk of death and logging information related to the increased risk of death. Also presented is a second method for determining and responding in real-time to an increased risk of death relating to a patient with epilepsy comprising receiving at least one of arousal data, responsiveness data or awareness data and determining an arousal index, a responsiveness index or an awareness index, where the indices are based on arousal data, responsiveness data or awareness data respectively.
    Type: Grant
    Filed: July 21, 2022
    Date of Patent: September 3, 2024
    Assignee: Flint Hills Scientific, L.L.C.
    Inventor: Ivan Osorio
  • Patent number: 12076555
    Abstract: Electrical sensing/stimulation apparatuses for positioning at least one electrode within body tissue are provided. An electrical sensing/stimulation apparatus may comprise an elongate lead body having at least one internal lumen, at least one sensing/stimulation electrode, a deployable/retractable displacement member that moves or biases at least one electrode towards a prescribed direction by the user, a tissue attachment mechanism for affixing the distal segment of the device to body tissue, and an atraumatic distal lead body termination. In a retracted configuration, the attachment mechanism is positioned substantially within the distal segment of the lead body, and in the deployed configuration, the attachment mechanism extends from the axis of the lead body to engage body tissue.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: September 3, 2024
    Assignee: Merit Medical Systems, Inc.
    Inventors: Kurt Sparks, Ellis Garai, Aravind Swaminathan, Laura Dietch, Marcel Sicotte
  • Patent number: 12029684
    Abstract: In certain embodiments, an ophthalmic surgical system for performing a surgical procedure on an eye comprises a laser device, a camera, and a computer. The laser device comprises a laser source and a scanner. The laser source generates a laser beam comprising pulses, and the scanner directs the pulses towards tissue of the eye according to a laser focal spot pattern. The camera captures surgical images of the eye. The computer instructs the laser device to direct the pulses towards the eye according to the laser focal spot pattern, accesses and monitor the surgical images of the eye, identifies an interfering object from the surgical images of the eye, and modifies the control of the pulses to compensate for the interfering object.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: July 9, 2024
    Assignee: Alcon Inc.
    Inventors: Mario Abraham, Michael Wittnebel